Insider filing · CELC
David Dalvey
Director
profile →
Celcuity Inc.
CELC · Healthcare · 11 filings in 24 months
ticker →
David Dalvey sold $4.7M of Celcuity (CELC)
Executed Jul 28 2025, disclosed Jul 30 2025, 2 days later.
Value, as filed
$4.7M
107,300 sh across 6 lots
Executed
Jul 28 2025
the trade date, as filed
Disclosed
Jul 30 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DDDavid Dalvey (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Celcuity Inc. (CELC). The largest single filing was $3.5M of CELC (25,000 sh × $140.68, as filed), executed May 4.
The name
CELCHealthcare · Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by David Dalvey in CELC
CELCSALE
Celcuity Inc.
$3.5M25,000 sh × $140.68
Exec May 4
Filed May 6 · 5:30 PM ET CELCSALE Celcuity Inc. $2.4M
20,000 sh × $120.03
Exec Jan 27
Filed Jan 29 · 5:30 PM ET CELCSALE Celcuity Inc. $1.5M
15,000 sh × $100.00
Exec Nov 21 2025
Filed Nov 24 2025 · 5:30 PM ET